The present invention relates to a composition and a method for combination therapy, which can be used to regulate the intrinsic dyfunctional nerve process at a time, and can be used to treat the dyfunctional nerve process at a time. According to the present invention, the composition can reduce neuropsychiatric disorders including but not limited to symptoms and/or symptoms of psychiatric stimulant use disorder (PUD: psychostimulant use disorder) and other substance-related addictive diseases, post-traumatic stress disorder (PTSD: post-traumatic stress disorder), other traumatic and stress-related disorders, levodopa-induced dyskinesia (LID: levodopa-induced dyskinesia), and other morphological dyskinesia, and can be used for treating neuropsychiatric disorders including but not limited to symptoms and/or symptoms of the dyskinesia, such as dyskinesia, dyskinesia, dyskinesia, dyskinesia, dyskinesia, dyskinesia, dyskinesia, dyskinesia, dyskinesia and dyskinesia. Specific examples of dosage forms are described.
Compositions and methods for treating neuropsychiatric disorders